Our vendor and supplier mapping project illustrates the biopharmaceutical industry's investment in our state economies and in the health of the patients we serve.
MD at a Glance
Launched in 2009, We Work For Health – Maryland is an effort to promote the significant social and economic value of the biopharmaceutical and life sciences sectors in our state. Our partnership includes biotechnology and pharmaceutical companies, as well as state and local chambers of commerce, academic and research institutions, labor, patient advocate groups, physicians and healthcare providers. Together, our mission is to drive innovation, research and development to new cures.
- The Atlantic Vaccines and Immunotherapeutics SummitMay 07, 2015
Innovate locally. Impact globally. The Atlantic Vaccines and Immunotherapeutics Summit is the premier event to showcase Maryland’s global leadership and role as the epicenter of vaccine innovation and development. The conference will give attendees a chance to interact, learn, and engage with the industry’s foremost researchers and business leaders, while tackling the pressing issues that face the new generation of vaccines. Participants will include prominent commercial, investment, regulatory, scientific, and academic organizations, as well as high-ranking officials from civilian and defense agencies at the state and federal levels.
- Maryland State Chamber of Commerce Annual Meeting & Business Hall of Fame AwardsMay 05, 2015
The Annual Meeting is the Chamber’s largest networking event of the year. In attendance will be CEOs and business executives representing hundreds of companies that comprise Maryland’s business community. Those present will be keenly interested in knowing what can be done to rapidly accelerate our State’s ability to expand the tax base, attract new companies, and improve the state’s competitiveness in private sector job creation and business investment.
- 3,064 vendor relationships
- $1,012,464,772 vendor spending
- #MD #medicaldevice company CSA Medical raises $2.9M to enhance unhealthy tissue removal #treatment availability http://t.co/wRgulqqfu6
3 days ago
- .@AstraZeneca & @Celgene announce collaboration to develop #antibody for #bloodcancers! http://t.co/OPVsski4fN
3 days ago
- HT @BioMaryland: Nine of the "50 Most Influential People in #Vaccines" are in #MD. http://t.co/dnBYKUrfTm
3 days ago
The Immune Deficiency Foundation (IDF), founded in 1980, is the national non-profit patient organization dedicated to improving the diagnosis, treatment and quality of life of persons with PI through advocacy, education and research. There are approximately 250,000 people who are diagnosed with PI in the U.S., and thousands more go undetected.Learn More
Global Biohazard Technologies, Inc. is a full-service biocontainment and biosafety consulting company staffed by biosafety professionals committed to providing state-of-the-art biosafety consultation to institutions and companies concerned with the design, construction, and operation of their biocontainment facilities.Learn More